Zimmer Biomet Chairman, President and CEO Ivan Tornos Joins OREF Board of Trustees
ROSEMONT, Ill., May 29, 2025 /PRNewswire/ -- The Orthopaedic Research and Education Foundation (OREF), the leading private nonprofit organization funding musculoskeletal (MSK) research across all orthopaedic sub-specialties, is pleased to announce that Ivan Tornos, Chairman, President and CEO of orthopaedic medical device company Zimmer Biomet has joined its Board of Trustees.
Mr. Tornos joined Zimmer Biomet in 2018 as Group President, Orthopedics. Prior to his appointment as President and Chief Executive Officer in 2023, he held the positions of Group President, Global Businesses and the Americas, and Chief Operating Officer with responsibility for overseeing all global businesses at Zimmer Biomet. He was elected Chairman of the Board of Directors of Zimmer Biomet, a global leader in musculoskeletal health, in May of 2025.
OREF Board President, Joshua J. Jacobs, MD, stated, "On behalf of the entire board, I am delighted to welcome Ivan to OREF. Our two organizations have a long history of collaboration and a shared commitment to improving patient care and outcomes. Ivan's presence on the OREF board will bring heightened visibility to our mission and to the need for more research funding. His service to OREF and the financial support of Zimmer Biomet underscore his commitment to improving the health of our communities here in the U.S. and throughout the world."
"I am thrilled to be joining the OREF board. Now more than ever, it's important we move with a sense of urgency and deep purpose to ensure that musculoskeletal research advances at a much faster pace and delivers even bolder solutions. There are countless patients currently waiting on the sidelines who could benefit from the meaningful work that we will do together, and I'm committed to doing all I can to reduce the current gaps in this area," said Ivan Tornos.
The growing burden of MSK conditions in the United States is well documented with MSK-related diseases and injuries affecting more than half of the adult population and imposing an estimated economic burden of $980 billion annually.1 Despite the outsized impact of MSK diseases on quality of life and the U.S. economy, funding for MSK conditions is disproportionately low when comparing the physical and economic burden of various diseases. OREF is a leading voice in advocating for increased MSK research funding and strongly believes that the nation's healthcare will not improve unless and until MSK research funding becomes a national priority.
OREF grantees' success in securing additional funding from the NIH and other government entities is unparalleled within the MSK research community. Research published in JBJS demonstrates that OREF grant recipients are more likely to receive subsequent NIH funding compared to other applicants (23.5 percent vs. 20.6 percent), with Career Development Grant recipients achieving a 48.4 percent success rate.2 Given the limited availability of MSK research funds, investing in a reputable independent source with a proven return on investment is essential. OREF's collaboration with more than 60 MSK-related organizations is a key factor in its success in funding significant and impactful research that improves clinical practice and patient outcomes.
About OREF
An independent 501(c)3 nonprofit, OREF strives to improve clinical care and patient outcomes by advancing innovative research, developing new investigators, and uniting the orthopaedic community in promoting musculoskeletal health. The Foundation raises funds to support research on diseases and injuries of bones, nerves, muscles, and tendons and to enhance clinical care leading to improved health, increased activity, and a better quality of life for patients. For more information, visit oref.org or follow OREF on X and LinkedIn.
1United States Bone and Joint Initiative: The Burden of Musculoskeletal Diseases in the United States (BMUS), Third Edition, 2014. Rosemont, IL. Available at https://bmus.latticegroup.com/fourth-edition/if0/healthcare-utilization-and-economic-cost
2Li, Alan K. BS1,a; Kendal, Joseph K. MD, MSc2; Hamad, Christopher D. MD2; Peterson, Nicholas V. MD2; Asachi, Parsa BA1; Taylor, Jeremiah M. BS1; Le, Michael M. MD1; Lloyd, Trevor S. BS1; Wessel, Lauren E. MD2; Bernthal, Nicholas M. MD2. Identifying Predictors of Successful Conversion from OREF Grants to Extramural Federal Funding Among Orthopaedic Surgeons. The Journal of Bone and Joint Surgery 107(1):p 96-103, January 1, 2025. DOI: 10.2106/JBJS.24.0064
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-chairman-president-and-ceo-ivan-tornos-joins-oref-board-of-trustees-302466210.html
SOURCE Orthopaedic Research and Education Foundation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
13 hours ago
- Miami Herald
Some Johns Hopkins, UMD research stopped after Trump cuts. Others are scrambling to resume
BALTIMORE - Some Maryland university research projects on the Trump administration's chopping block have been fully discontinued, while others are scrambling to resume after a pause in funding. Johns Hopkins has lost more than $800 million in federal grant money. The University of Maryland lost tens of millions of dollars. But some cuts have been blocked by legal challenges, though litigation is ongoing. Researchers describe disappointment and uncertainty as they determine how to move forward. Alternative funding has been secured for a clinical trial in Bangladesh aimed at managing life-threatening diarrheal diseases in children, which was previously halted because of U.S. Agency for International Development funding cuts. The work has yet to resume. "It just takes a long time to rebuild the teams and get things in place again to start," said Judd Walson, chair of the Department of International Health at Johns Hopkins University, which partnered on the project. "The disruptions that are happening are really catastrophic." Over the past several weeks, 17 NIH awards have been terminated or had an unclear status, including two training awards supporting doctoral-level researchers, Walson said. "We're not getting a lot of communication, so it's a little bit hard to say exactly what the status of some of these awards are," he said. The National Institutes of Health didn't respond to questions about funding cuts to Maryland research institutions. In a lawsuit challenging NIH research cuts, lawyers for the federal government wrote in a recent court filing that its terminations of grants for DEI-related studies were "sufficiently reasoned," and that the NIH has "broad discretion" to decide what grants to provide. Johns Hopkins is a plaintiff in two lawsuits involving caps on reimbursement of indirect costs for research - one challenging the NIH and the other against the Department of Defense. The latter suit also lists the University of Maryland, College Park, as a plaintiff. Both schools have also filed a brief in support of a lawsuit filed by Harvard University against the Trump administration's funding cuts. New grant terminations have been arriving "nearly every week," Johns Hopkins University said in a recent update published on its website. There's also been a nearly two-thirds decrease in new awards compared with last year, the university said. Johns Hopkins atmosphere and ocean sciences researcher Darryn Waugh was disappointed upon receiving notice that his NASA grant to study air pollution in Baltimore was canceled by the Trump administration. The termination came as a result of President Donald Trump's executive order, "Ending Radical and Wasteful Government DEI Programs and Preferencing." "It wasn't clear to me that this actually falls under this diversity, equity, inclusion," Waugh said. "It was research that I think we still wanted to do - to understand how the air pollution varies through the city - and the environmental justice was only actually a relatively small component of it." Waugh was working through the second year of a three-year grant, totaling $1,465,950. "We've got kind of a preliminary analysis," he said, regarding the research. "But to get anything conclusive, we would need more than one year of funding." Waugh said he intends to find ways of continuing the research without the NASA grant. Daniel Mullins, at the University of Maryland School of Pharmacy, had a grant canceled for a "Health Equity Research Hub," which examined how to encourage greater participation in health-related research. Mullins said the loss of the grant affected five positions, and the individuals will be removed from the university because of lack of funding. He added that the termination stated that the grant was DEI-related, which he disputes. "I think under the DEI umbrella, a lot of times, the government will refer to it as just one racial ethnic group," he said. "We've worked in different geographies, in different racial and ethnic populations, but what's cool about what we do is it really does apply to all patients in all populations." Mullins said his research group has additional funding from other agencies and is writing new proposals. Walson said social determinants of health - involving factors like poverty and other "inequities" - are "foundational to our understanding of health." "So the idea that we would not be able to pursue work that focuses on identifying and managing those particular issues, which are the underlying, core issues at the heart of health issues, is really challenging," Walson said. The Trump administration's cuts have had an ieffect across the world. Walson said it's estimated the cuts will result in hundreds of thousands of deaths globally, and could eventually lead to millions of deaths over the next couple of years. Secretary of State Marco Rubio has said it's "a lie" that people have died because of USAID cuts. During a congressional hearing in May, Rubio said the U.S. is the world's "largest humanitarian provider." "I would argue: How many people die because China hasn't done it?" he said. "How many people have died because the U.K. has cut back on spending and so has other countries?" Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Miami Herald
13 hours ago
- Miami Herald
What Trump's Strikes on Iran Mean for Gas Prices As Oil Costs Surge
Amid the conflict between Israel and Iran, oil prices have been surging, and after President Donald Trump announced on Saturday the U.S. would be joining the attack on Iran's nuclear sites, concern has been raised over what this means for gas prices in America. The U.S. dropped bombs on Iran's three main nuclear sites on Saturday night—Fordow, Natanz and Isfahan—escalating fears of an expansion of the Middle Eastern conflict that could throw the oil market into turmoil. With much of the West already seeing spikes in costs, further increases could be looming as the conflict continues. After the U.S. attack, the Iran's reaction will reveal whether the conflict could develop into a major regional or even international conflict. Iran may retaliate against U.S. forces in the region, cut off a global oil supply route or try to accelerate its nuclear program. Although, Trump has warned of further military action if Tehran does not now decide to make peace. In the past week, Brent Crude oil stocks have already jumped 11 percent since Israel attacked Iran and is expected to continue rising on Monday, according to Emirati newspaper Gulf News, although prices have been fluctuating. The oil market had stabilized on Friday, according to Reuters, after the U.S. imposed new Iran-related sanctions, which fueled hopes that a negotiated agreement could be made between the two countries. That relief in the market was only temporary as after Iran threatened to close the Strait of Hormuz, the world's most important oil chokepoint, in response to the U.S. strikes. Fears that Iran could attack U.S. oil infrastructure in the region, and levy its power over the Straits of Hormuz could "combine to make prices and speculation rise about the security and dependability of supply," Greg Kennedy, director of the Economic Conflict and Competition Research Group at King's College London told Newsweek. "Lack of clarity of how long this condition will last will also lead to hoarding or preemptive purchasing by other nations, so there are competition supply fears that will drive up prices," he added. Reflecting on the knock-on effect this would have on U.S. gas prices, Kennedy said that in the long term, the conflict "will most certainly see energy prices go up at the pumps." "This is not an act that just stays in the Gulf region, it has wider global strategic ripples," he said. Kennedy said that higher oil prices could also mean that Russia is able to gain more money—oil from the Urals region has already increased by 26 percent in the past month. "This is making war in Ukraine last longer now as well as it gives [President Vladimir] Putin both political and economic ammunition to continue his war efforts and avoid the need for peace talks." Greg Kennedy, director of the Economic Conflict and Competition Research Group at King's College London told Newsweek: "The overall impact of actions that make the world look even less safe than it was previously was is always a cost to the civilian sector and society as a whole." As the conflict, and its repercussions, continue to unfold in the next few days, it will become more clear how significant the prices hikes will be. Related Articles Donald Trump Warns Iran Against 'Any Retaliation' After US Strikes: Live UpdatesExclusive: Hezbollah Says It Won't Join Fight After US Attacks IranTrump Warns Iran To Make Peace or Face Further StrikesAOC Says Trump's Iran Strikes 'Clearly Grounds for Impeachment' 2025 NEWSWEEK DIGITAL LLC.
CNBC
14 hours ago
- CNBC
Oil to open higher as U.S. strikes on Iran boost supply risk premium
Oil is likely to rise by $3 to $5 per barrel when trading resumes on Sunday evening after the U.S. attacked Iran at the weekend, market analysts said, with gains expected to accelerate only if Iran retaliates hard and causes a major oil supply disruption. U.S. President Donald Trump said he had "obliterated" Iran's main nuclear sites in strikes overnight, joining an Israeli assault in an escalation of conflict in the Middle East as Tehran vowed to defend itself. Iran is OPEC's third-largest crude producer. Global oil benchmark Brent crude could gain $3 to $5 per barrel when markets open, SEB analyst Ole Hvalbye said in a note. Brent settled at $77.01 a barrel on Friday and U.S. crude oil at $73.84 a barrel. "An oil price jump is expected," said Jorge Leon, head of geopolitical analysis at Rystad and a former OPEC official. "Even in the absence of immediate retaliation, markets are likely to price in a higher geopolitical risk premium." Crude had settled down on Friday after the U.S. imposed fresh Iran-related sanctions, including on two entities based in Hong Kong, and counter-terrorism-related sanctions, according to a notice posted to the U.S. Treasury Department website. Brent has risen 11% while WTI has gained around 10% since the conflict began on June 13 with Israel targeting Iran's nuclear sites and Iranian missiles hitting buildings in Tel Aviv. Currently stable supply conditions and the availability of spare production capacity among other OPEC members have limited oil's gains. Risk premiums have typically faded when no supply disruptions occurred, said Giovanni Staunovo, analyst at UBS. "The direction of oil prices from here will depend on whether there are supply disruptions — which would likely result in higher prices — or if there is a de-escalation in the conflict, resulting in a fading risk premium," he said. A senior Iranian lawmaker on June 19 said that the country could shut the Strait of Hormuz as a way of hitting back against its enemies, though a second member of parliament said this would only happen if Tehran's vital interests were endangered. About a fifth of the world's total oil consumption passes through the strait. SEB said that any closure of the strait or spillover into other regional producers would "significantly lift" oil prices, but said they saw this scenario as a tail risk rather than a base case given China's reliance on Gulf crude. Ajay Parmar, oil and energy transition analytics director at consultancy ICIS, said it was unlikely Iran would be able to enforce a blockage of the strait for too long. "Most of Iran's oil exports to China pass through this strait and Trump is unlikely to tolerate the inevitable subsequent oil price spike for too long — the diplomatic pressure from the world's two largest economies would also be significant," he said.
